STOCK TITAN

GreenLight Biosciences Holdings PBC - GRNA STOCK NEWS

Welcome to our dedicated news page for GreenLight Biosciences Holdings PBC (Ticker: GRNA), a resource for investors and traders seeking the latest updates and insights on GreenLight Biosciences Holdings PBC.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GreenLight Biosciences Holdings PBC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GreenLight Biosciences Holdings PBC's position in the market.

Rhea-AI Summary
GreenLight Biosciences Holdings has completed its merger with SW MergerCo and SW ParentCo, resulting in GreenLight becoming a wholly-owned subsidiary of Parent. Following the merger, GreenLight shares and warrants will no longer be listed on the NASDAQ. Each remaining share of GreenLight common stock will be converted into the right to receive $0.30 in cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
GreenLight Biosciences Holdings, PBC is set to complete its merger with SW MergerCo, Inc. and SW ParentCo, Inc. on July 20, 2023. Following the merger, GreenLight's common stock will no longer be traded on NASDAQ. A total of 18,791,264 shares of GreenLight common stock were tendered and not withdrawn, representing approximately 60.4% of outstanding shares. Each remaining share will be converted into the right to receive $0.30 in cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
45.51%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.35%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.15%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.13%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.49%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.73%
Tags
conferences
GreenLight Biosciences Holdings PBC

Nasdaq:GRNA

GRNA Rankings

GRNA Stock Data

45.43M
Research and Development in Biotechnology
Professional, Scientific, and Technical Services

About GRNA

greenlight biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented cell free bioprocessing technology platform. this revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.